Education
About Us
Working with TipRanks
Follow Us
Gufic Biosciences Limited (IN:GUFICBIO)
:GUFICBIO
GUFICBIO Stock Chart & Stats
₹345.40
-₹9.05(-1.92%)
At close: 4:00 PM EST
₹345.40
-₹9.05(-1.92%)
Day’s Range― - ―
52-Week Range₹285.00 - ₹497.75
Previous CloseN/A
Volume28.80K
Average Volume (3M)2.36K
Market Cap
₹35.24B
Enterprise Value₹41.42B
Total Cash (Recent Filing)₹290.22M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)61.9
Beta0.80
Next Earnings
Feb 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.03%
Share Statistics
EPS (TTM)1.68
Shares Outstanding100,282,510
10 Day Avg. Volume2,111
30 Day Avg. Volume2,356
Financial Highlights & Ratios
PEG Ratio-2.39
Price to Book (P/B)5.63
Price to Sales (P/S)4.13
P/FCF Ratio124.94
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Gufic Biosciences Limited News
GUFICBIO FAQ
What was Gufic Biosciences Limited’s price range in the past 12 months?
Gufic Biosciences Limited lowest stock price was ₹285.00 and its highest was ₹497.75 in the past 12 months.
What is Gufic Biosciences Limited’s market cap?
Gufic Biosciences Limited’s market cap is ₹35.24B.
When is Gufic Biosciences Limited’s upcoming earnings report date?
Gufic Biosciences Limited’s upcoming earnings report date is Feb 12, 2026 which is in 56 days.
How were Gufic Biosciences Limited’s earnings last quarter?
Gufic Biosciences Limited released its earnings results on Nov 14, 2025. The company reported ₹1.678 earnings per share for the quarter, beating the consensus estimate of N/A by ₹1.678.
Is Gufic Biosciences Limited overvalued?
According to Wall Street analysts Gufic Biosciences Limited’s price is currently Overvalued.
Does Gufic Biosciences Limited pay dividends?
Gufic Biosciences Limited pays a Annually dividend of ₹0.1 which represents an annual dividend yield of 0.03%. See more information on Gufic Biosciences Limited dividends here
What is Gufic Biosciences Limited’s EPS estimate?
Gufic Biosciences Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Gufic Biosciences Limited have?
Gufic Biosciences Limited has 100,282,510 shares outstanding.
What happened to Gufic Biosciences Limited’s price movement after its last earnings report?
Gufic Biosciences Limited reported an EPS of ₹1.678 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.915%.
Which hedge fund is a major shareholder of Gufic Biosciences Limited?
Currently, no hedge funds are holding shares in IN:GUFICBIO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Gufic Biosciences Limited
Gufic Biosciences Limited (GUFICBIO) is a leading Indian pharmaceutical and biotechnology company that specializes in the manufacture and marketing of a diverse range of pharmaceutical formulations, biopharmaceuticals, and herbal products. The company operates in various sectors, including healthcare, pharmaceuticals, and biotechnology, with a strong emphasis on research and development to innovate and enhance its product offerings. Gufic Biosciences is known for its commitment to quality and has a portfolio that includes injectables, tablets, and specialty products aimed at treating various medical conditions.
Technical Analysis
Hikal Limited
―
Indoco Remedies Limited
―
IOL Chemicals & Pharmaceuticals Ltd.
―
Morepen Laboratories Limited
―
Orchid Pharma Limited
―